Z1P - The Rise To $15.00, page-187

First 187 Last

Share
Profile

Follow
vwboy

5,642 Posts.

365

12/09/20

18:37

Post #: 47293955
Share

Originally posted by Goodfella58 ↑

I've been in the markets for over thirty years and brokered major deals with some of the leading merchant banks so have first hand knowledge of what happens in the "City"

A lot of these "jam tomorrow " stocks exist for the single purpose of making the founders rich and have zero chance of ever making a profit.

The market history is littered with "darlings " who eventually go bust .

On the 21 st August the price was $6.63 and a large green candle the following day as The E Bay news was leaked.

The news was released on the 26 th the day before the full year results which can only be described as horrendous.

This really was a "fluff" announcement and not worthy of a seperate announcement outside of the full year results.

After initial excitement to the headline figures the price has now crashed 44 per cent from its highs

In reality those results were shocking and worthy of a 44 per cent crash in price from $6.63 resulting in a share price of $3.71

The headline numbers were bad but getting deeper into the accounts they reduced the losses by a $47.5 increase in value of Quadpay.

Real cash item losses were $70 million and bad debts a staggering 33 % of revenue.

It takes a staggering level of financial mis-management to produce that level of losses and bad debts on only $ 160 million of revenue

Of course this revaluation was nonsense even before PayPal announcement.

I note they have drawn over a billion $ of warehouse facility and had very little headroom left on borrowings.

Post balance sheet this was increased to $164 million headroom so they have very little borrowing capacity left to grow the business in Australia.

The reason there is such heavy short interest is they only have $32 million in cash and a similar amount in excess of receivables over borrowings

With the full ownership of Quadpay those losses are going to accelerate and they will need to come back to market within six to 12 months but their financials are so dire that it would need to be at a extremely heavy discount and significant dilution.

i can see another CLH here which has been suspended for months and may never return to market.

All IMHO and DYOR

Expand

Really?
In reality those results were shocking and worthy of a 44 per cent crash in price from $6.63 resulting in a share price of $3.71

Z1P Price at posting: $5.99 Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

Failure to report prompts ASX to impose multiple company suspensions

LU7

Strong PFS numbers solidify Lithium Universe's big plans for Québec

IRE

Iress runs 'hot' for Wealth Within's stock tips

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

There are more pages in this discussion • 1,308 more messages in this thread...

First 187 Last

Add ZIP (ASX) to my watchlist

(20min delay)
Last $2.75		Change 0.000(0.00%)		Mkt cap ! $3.590B

Open	High	Low	Value	Volume
$2.74	$2.75	$2.69	$17.99M	6.602M

Buyers (Bids)

No.	Vol.	Price($)
1	100000	$2.74

Sellers (Offers)

Price($)	Vol.	No.
$2.75	83683	13

View Market Depth

No.	Vol.	Price($)
1	100000	2.740
3	2884	2.730
11	124285	2.720
16	339665	2.710
14	217134	2.700

Price($)	Vol.	No.
2.750	83683	13
2.760	408954	18
2.770	202607	6
2.780	267064	12
2.790	195836	11

Last trade - 16.10pm 01/10/2024 (20 minute delay)

ZIP (ASX) Chart

Z1P - The Rise To $15.00, page-187

Failure to report prompts ASX to impose multiple company suspensions

Strong PFS numbers solidify Lithium Universe's big plans for Québec

Iress runs 'hot' for Wealth Within's stock tips

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Z1P - The Rise To $15.00, page-187

Top Stories

Failure to report prompts ASX to impose multiple company suspensions

Strong PFS numbers solidify Lithium Universe's big plans for Québec

Iress runs 'hot' for Wealth Within's stock tips

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News